Close Menu

cytogenetics

Baylor College of Medicine's department of molecular and human genetics has been an Agilent Technologies customer for nearly a decade, and the Santa Clara, Calif.-based microarray vendor has produced many iterations of custom-designed chips for BCM.

NEW YORK (GenomeWeb News) – Precipio Diagnostics has raised $1.8 million in a Series B financing round, Connecticut Innovations, the lead investor in the round, said today.

Name: Peter Papenhausen
Title: National Director of Cytogenetics, Laboratory Corporation of America

This story was originally posted on Aug. 1.
Affymetrix posted a 20 percent rise in second-quarter revenues last week, largely due to a contribution from its eBioscience business, but also driven by double-digit growth in genotyping array sales.

NEW YORK (GenomeWeb News) – Cancer genetics diagnostic company NeoGenomics today reported flat revenues for the second quarter, as changes to Medicare's reimbursement for molecular diagnostics negatively impacted operations.

A quartet of recent papers authored by geneticists at Birmingham Women's Hospital has shed greater light on the application of chromosomal microarrays in prenatal diagnostics in the UK.

Geneticists who use microarrays to detect chromosomal abnormalities have two new tools at their disposal.

While many in the cytogenetics world are concerned with array findings of unclear clinical significance, and how to communicate that information back to patients, a recent review conducted within Cleveland Clinic Laboratories found that it was the lab's sample preparation method

SciGene this week launched CytoZyme Stabilized Pepsin, an advanced liquid formulation of pepsin for pre-treating tissue samples in nucleic acid probe-based cytogenetic assays.

This story was originally posted on June 17.

Pages

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.